Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours
Background: Prostate Specific Antigen (PSA) is secreted by prostate gland as well as hormonally regulated tissues such as breast, ovaries and endometrium. We aimed to assess the utility of serum total and free PSA in combination with carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 1...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Series: | Journal of Clinical and Scientific Research |
| Subjects: | |
| Online Access: | http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2018;volume=7;issue=4;spage=159;epage=164;aulast=Swathi |
| _version_ | 1818509715227803648 |
|---|---|
| author | Pyreddy Swathi N Lakshmanna Kanchi Rama A R Bitla P. V L. N Srinivasa Rao Hulikal Narendra Yootla Mutheeswaraiah Amancharla Yadagiri Lakshmi B V Phaneendra |
| author_facet | Pyreddy Swathi N Lakshmanna Kanchi Rama A R Bitla P. V L. N Srinivasa Rao Hulikal Narendra Yootla Mutheeswaraiah Amancharla Yadagiri Lakshmi B V Phaneendra |
| author_sort | Pyreddy Swathi |
| collection | DOAJ |
| description | Background: Prostate Specific Antigen (PSA) is secreted by prostate gland as well as hormonally regulated tissues such as breast, ovaries and endometrium. We aimed to assess the utility of serum total and free PSA in combination with carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in diagnosis of breast cancer.
Methods: Seventy two female patients (38 with benign breast disease and 34 with malignant breast disease) who were histologically, cytologically confirmed with diagnosis of primary breast tumours were investigated. Serum total prostate specific antigen (PSA), Free PSA, CEA, CA 15-3 were analysed by enzyme linked immunosorbent assay (ELISA) method. Diagnostic performance of markers was studied using receiver operating characteristic curve and logistic regression analysis. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated.
Results: Patients with malignant breast cancer had significantly higher levels of all tumour markers compared to benign breast tumours. A significant decrease in total PSA, CEA and a statistically insignificant decrease in free PSA concentrations were seen in malignant breast cancer patients after surgery. Performance of total PSA was best among all the markers with 100% sensitivity, NPV, 94.7% specificity and 94.4% PPV.
Conclusions: Serum total PSA is a good diagnostic marker to differentiate benign breast disease from malignant tumours compared to currently used CEA and CA 15-3. |
| first_indexed | 2024-12-10T22:49:10Z |
| format | Article |
| id | doaj.art-eda02245167c49c9b61582533d402a9f |
| institution | Directory Open Access Journal |
| issn | 2277-5706 2277-8357 |
| language | English |
| last_indexed | 2024-12-10T22:49:10Z |
| publishDate | 2018-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Clinical and Scientific Research |
| spelling | doaj.art-eda02245167c49c9b61582533d402a9f2022-12-22T01:30:29ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Scientific Research2277-57062277-83572018-01-017415916410.4103/JCSR.JCSR_9_19Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumoursPyreddy SwathiN LakshmannaKanchi RamaA R BitlaP. V L. N Srinivasa RaoHulikal NarendraYootla MutheeswaraiahAmancharla Yadagiri LakshmiB V PhaneendraBackground: Prostate Specific Antigen (PSA) is secreted by prostate gland as well as hormonally regulated tissues such as breast, ovaries and endometrium. We aimed to assess the utility of serum total and free PSA in combination with carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in diagnosis of breast cancer. Methods: Seventy two female patients (38 with benign breast disease and 34 with malignant breast disease) who were histologically, cytologically confirmed with diagnosis of primary breast tumours were investigated. Serum total prostate specific antigen (PSA), Free PSA, CEA, CA 15-3 were analysed by enzyme linked immunosorbent assay (ELISA) method. Diagnostic performance of markers was studied using receiver operating characteristic curve and logistic regression analysis. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. Results: Patients with malignant breast cancer had significantly higher levels of all tumour markers compared to benign breast tumours. A significant decrease in total PSA, CEA and a statistically insignificant decrease in free PSA concentrations were seen in malignant breast cancer patients after surgery. Performance of total PSA was best among all the markers with 100% sensitivity, NPV, 94.7% specificity and 94.4% PPV. Conclusions: Serum total PSA is a good diagnostic marker to differentiate benign breast disease from malignant tumours compared to currently used CEA and CA 15-3.http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2018;volume=7;issue=4;spage=159;epage=164;aulast=Swathibreast cancercarbohydrate antigen 15-3carcinoembryonic antigenprostate-specific antigentumour markers |
| spellingShingle | Pyreddy Swathi N Lakshmanna Kanchi Rama A R Bitla P. V L. N Srinivasa Rao Hulikal Narendra Yootla Mutheeswaraiah Amancharla Yadagiri Lakshmi B V Phaneendra Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours Journal of Clinical and Scientific Research breast cancer carbohydrate antigen 15-3 carcinoembryonic antigen prostate-specific antigen tumour markers |
| title | Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours |
| title_full | Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours |
| title_fullStr | Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours |
| title_full_unstemmed | Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours |
| title_short | Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours |
| title_sort | utility of serum total and free prostate specific antigen in combination with serum carbohydrate antigen 15 3 and carcinoembryonic antigen in breast tumours |
| topic | breast cancer carbohydrate antigen 15-3 carcinoembryonic antigen prostate-specific antigen tumour markers |
| url | http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2018;volume=7;issue=4;spage=159;epage=164;aulast=Swathi |
| work_keys_str_mv | AT pyreddyswathi utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT nlakshmanna utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT kanchirama utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT arbitla utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT pvlnsrinivasarao utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT hulikalnarendra utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT yootlamutheeswaraiah utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT amancharlayadagirilakshmi utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours AT bvphaneendra utilityofserumtotalandfreeprostatespecificantigenincombinationwithserumcarbohydrateantigen153andcarcinoembryonicantigeninbreasttumours |